BDX · ASX

BCAL Diagnostics Limited (ASX:BDX)

AU$0.096

 0.006 (6.667%)
ASX:Live
20/12/2024 04:10:10 PM
HALO Ords GROWTH AUS EMA 125 Breakdown All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BDX Overview

BDX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About BDX

Website

N/A

Telephone

N/A

Address

Description

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.

BDX Price Chart

Key Stats

Market Cap

AU$33.00M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.09 - 0.19

Trade Value (12mth)

AU$11,395.00

1 week

-12.2%

1 month

-14.29%

YTD

-7.22%

1 year

-9.09%

All time high

0.28

Key Fundamentals

EPS 3 yr Growth

266.20%

EBITDA Margin

N/A

Operating Cashflow

-$5m

Free Cash Flow Return

-57.30%

ROIC

-81.10%

Interest Coverage

-88.30

Quick Ratio

3.60

Other Data

Shares on Issue (Fully Dilluted)

256m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BDX Announcements

Latest Announcements

Date Announcements

19 December 24

Application for quotation of securities - BDX

×

Application for quotation of securities - BDX

19 December 24

Application for quotation of securities - BDX

×

Application for quotation of securities - BDX

19 December 24

Notification regarding unquoted securities - BDX

×

Notification regarding unquoted securities - BDX

19 December 24

Change of Directors Interest Notices X 6

×

Change of Directors Interest Notices X 6

19 December 24

Notification of cessation of securities - BDX

×

Notification of cessation of securities - BDX

19 December 24

Notification regarding unquoted securities - BDX

×

Notification regarding unquoted securities - BDX

19 December 24

Cleansing Notice

×

Cleansing Notice

12 December 24

BCAL Diagnostics Receives NATA Accreditation

×

BCAL Diagnostics Receives NATA Accreditation

12 December 24

NATA Accreditation Clarification

×

NATA Accreditation Clarification

27 November 24

Results of Meeting Revised

×

Results of Meeting Revised

26 November 24

BCAL Receives R&D Tax Offset $2.6 Million

×

BCAL Receives R&D Tax Offset $2.6 Million

22 November 24

Annual General Meeting Presentation

×

Annual General Meeting Presentation

22 November 24

Results of Meeting

×

Results of Meeting

14 November 24

Australian Patent Accepted for BREASTEST Technology

×

Australian Patent Accepted for BREASTEST Technology

12 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

05 November 24

BCAL Commercial Update

×

BCAL Commercial Update

31 October 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 October 24

Publication in Peer-Reviewed Journal

×

Publication in Peer-Reviewed Journal

22 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

22 October 24

Letter to Shareholders re AGM Notice

×

Letter to Shareholders re AGM Notice

16 October 24

Shareholder Update

×

Shareholder Update

04 October 24

AGM Date and Director Nominations

×

AGM Date and Director Nominations

27 September 24

Appendix 4G Corporate Governance Statement

×

Appendix 4G Corporate Governance Statement

23 September 24

BCAL Secures Commercial Licence Agreement with SBC

×

BCAL Secures Commercial Licence Agreement with SBC

19 September 24

Corporate Presentation September 2024

×

Corporate Presentation September 2024

BDX Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -133.8 -44.6 -8.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.03 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -131.8 -53.5 25.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -19.9 -43.4 -18.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.05 0.02 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.05 0.02 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 177.2 -47.2 11.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 204 211 246 Lock Lock Lock
Basic m Lock Lock Lock Lock 204 211 246 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 8 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -451.3 -410.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -8 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -126.8 -90.6 -13.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -4 -8 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -128.0 -92.4 -19.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -4 -8 -9 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -3 -3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -5 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -122.0 -49.5 -26.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -6 -5 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -4 4 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 9 0 9 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -6 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -168.1 -97.5 11.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 10 3 6 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 11 8 12 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -10 -2 -5 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 3 4 Lock Lock Lock
Equity $m Lock Lock Lock Lock 10 5 9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 10 6 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 167.3 -36.6 58.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -32.0 -60.5 -52.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -35.1 -97.1 -74.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -62.0 -99.3 -114.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -51.1 -64.3 -81.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -48.6 -76.8 -57.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A -485.4 -88.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.3 0.3 0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -99.3 -40.5 -57.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 11.0 2.7 3.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 11.0 2.7 3.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 91.5 51.2 69.3 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -338.7 -267.5 -174.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -32.0 -60.5 -52.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.6 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -35.1 -97.1 -74.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -35.1 -97.1 -74.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 4,673.5 2,984.5 730.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -4,673.5 -2,984.5 -730.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BDX Shortsell

Frequently Asked Questions

The current share price of BCAL Diagnostics Limited (BDX:ASX) is AU$0.096.
The 52-week high share price for BCAL Diagnostics Limited (BDX:ASX) is AU$0.19.
The 52-week low share price for BCAL Diagnostics Limited (BDX:ASX)? is AU$0.09.
BCAL Diagnostics Limited (BDX:ASX) does not pay a dividend.
BCAL Diagnostics Limited (BDX:ASX) does not pay a dividend.
BCAL Diagnostics Limited (BDX:ASX) has a franking level of 0.0%.
BCAL Diagnostics Limited (BDX:ASX) is classified in the Healthcare.
The current P/E ratio for BCAL Diagnostics Limited (BDX:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.